Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Pain
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Pain
    TopAbstracts in Pain 11/27/2008 - (DGNews)
    FDA Approves Tapentadol for Relief of Moderate to Severe Acute Pain - (DGNews)
    TopAbstracts in Pain 11/20/2008 - (DGNews)
    TopAbstracts in Pain 11/13/2008 - (DGNews)
    TopAbstracts in Pain 11/06/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Pain
      Chronic Pain Patients on Opioid Therapy
      Chronic Pain Management in Primary Care: Individualizing Pain Relief and Improving Quality of Life
      Acute Pain Management and Opioid Treatment: Community Pharmacist Perspectives
      Enhanced NSAID Delivery: Emerging Technologies
      Balanced Opioid Prescribing

      Webcasts/CME archive

       Recent cases - Pain
        Pain in Both Knees
        Ketamine as an Adjuvant in Sympathetic Blocks for Management of Central Sensitization Following Peripheral Nerve Injury
        Sciatica Due to Extrapelvic Heterotopic Ossification: A Case Report
        Factitious Lymphoedema as a Psychiatric Condition Mimicking Reflex Sympathetic Dystrophy: A Case Report
        Gluteal Pyomyositis as a Rare Cause of Sciatica in a Temperate Region: A Case Report

        Cases archive
          




        my personal edition > pain > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Gabapentin Effective for Spinal Cord Injury in Those Able to Tolerate Side-Effects

        Clinical Journal of Pain

        04/22/2002
        By Mark Moran


        Gabapentin may be an effective treatment of pain after spinal cord injury among those able to tolerate initial and long-term side effects, say John David Putzke, PhD, and colleagues at the University of Alabama, Birmingham, Alabama, United States.

        Of 27 patients with spinal cord injury placed on an experimental trial of gabapentin and contacted six months later, 14 reported a favourable response to the agent. Favourable response was defined as a reduction of two points or more on a 0-10 pain-rating scale.

        Six of the 27 discontinued the drug because of intolerable side effects, however, the investigators report.

        A second follow-up interview 36 months after the original trial captured 11 of the 14 patients reporting a favorable response at the first interview. Of those, ten continued to report that gabapentin was an effective analgesic. There was no evidence to suggest dosing difficulties due to tolerance over the three-year period.

        Sedation, dizziness, and forgetfulness were the most common side effects, the investigators say.
        Clinical Journal of Pain 2002;18:116-121.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send